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Abstract. Oxaliplatin-based chemotherapy plays an important 
role in the treatment of colorectal liver metastases. Oxaliplatin, 
however, causes sinusoidal obstruction syndrome (SOS), 
which is characterized by portal hypertension, splenomegaly, 
thrombocytopenia, and liver dysfunction. SOS is diagnosed 
histopathologically by disruption of the sinusoidal endothe-
lium, collagen deposition, fibrosis especially around zone 3, 
dilatation of the sinusoidal space and congestion. This study 
assessed the characteristics of a rat model of SOS. SOS was 
induced in rats by administration of monocrotaline (MCT). 
Blood chemistries and macroscopic and microscopic findings 
were compared in rats administered MCT and vehicle (control 
group). Levels of expression in the liver of CD41, P-selectin, rat 
endothelial cell antigen-1, CD34, and cleaved caspase-3 were 
analyzed immunohistochemically. Moreover, livers of these 
rats were analyzed by electron microscopy. Macroscopically, 
MCT-treated rats showed accumulation of bloody ascites and 
blue liver and were diagnosed with SOS histologically. Serum 
concentrations of aspartate aminotransferase (P=0.003), 
alanine aminotransferase (P=0.008), total-bilirubin (P=0.012), 
direct-bilirubin (P=0.007), indirect-bilirubin (P=0.003), lactate 
dehydrogenase (P<0.001) and hyaluronic acid (P=0.016) were 
significantly higher, and platelet counts significantly lower 
(P=0.004), in MCT-treated than in control rats. The livers of 
MCT-treated rats were immunohistochemically positive for 
CD41 and P-selectin, suggesting platelet aggregates; for rat 
endothelial cell antigen-1 and CD34, suggesting sinusoidal 
endothelial disorder; and for cleaved caspase-3, suggesting 
hepatocyte apoptosis. Electron microscopic findings revealed 
platelet aggregation in the space of Disse in the MCT group. 
Extravasated platelet aggregation in Disse's space may be 
involved in the development of SOS.
Introduction
Systemic neoadjuvant chemotherapy can precede conver-
sion surgery, resulting in R0 resection, even in patients with 
initially unresectable colorectal liver metastases (CRLM). 
Although oxaliplatin-based chemotherapy plays a central role 
in the treatment of patients with CRLM, oxaliplatin can induce 
sinusoidal obstruction syndrome (SOS), which is characterized 
by hepatic sinusoidal dilatation, hepatocyte atrophy, peri-sinu-
soidal fibrosis, and nodular regenerative hyperplasia (1). These 
histological changes have been reported in up to 40% of 
patients treated with oxaliplatin-based regimens undergoing 
liver resection (2-6). SOS prior to major hepatectomy has 
been associated with increased peri-operative morbidity and 
prolonged hospital stay (7). Clinically, factors diagnostic of 
SOS include portal hypertension, splenomegaly, thrombocy-
topenia, an abnormal indocyanine green (ICG) retention rate 
and elevated liver enzymes, bilirubin and hyaluronic acid 
(HA) (8-12). On pathological examination, SOS is character-
ized by the disruption of the sinusoidal endothelium, collagen 
deposition in peri‑sinusoidal spaces, fibrosis especially around 
the central vein (in zone 3), dilatation of the sinusoidal space 
and congestion (13). Platelets were shown to be involved 
in the alterations in the sinusoidal endothelium observed 
in patients with SOS (14). Thrombocytopenia has been 
observed in patients with CRLM treated with oxaliplatin based 
chemotherapy, and examination of their resected livers showed 
platelet aggregation in zone 3 (15). Platelet aggregation in the 
extra-sinusoidal (Disse's) space is called extravasated platelet 
aggregation (EPA). This study assessed whether EPA was 
present in the livers of rats with drug induced SOS.
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Materials and methods
Reagents. Monocrotaline (MCT) was purchased from Wako 
Pure Chemical Industries (Osaka, Japan). A 20 mg/ml solution 
of MCT was prepared by dissolving 1,000 mg MCT in 1.0 N 
HCl, and adjusting the pH to 7.4 with 0.5 N NaOH, followed 
by dilution in phosphate-buffered saline (PBS), pH 7.4, to 
increase the total volume to 50 ml (16,17).
Animals. Male Wistar rats, weighing 230-300 g, were 
purchased from Charles River Inc. (Kanagawa, Japan), and 
allowed free access to water and standard laboratory chow. 
This study complied with the guidelines of the Division for 
Animal Research Resources, University of Kanazawa. All 
experiments and procedures were approved by the Animal 
Care and Use Committee of the University of Kanazawa.
Experimental protocol. The animals were randomly divided 
into two groups of 10 rats each. Animals were fasted for 12 h, 
with one group administered MCT (90 mg/kg) and the control 
group administered water (Fig. 1). Rats were thereafter allowed 
free access to water and standard laboratory chow ad libitum. 
Because histopathological changes 48 h after MCT admin-
istration are similar to those in patients with SOS, (16,18) 
the rats were anesthetized by inhalation of diethyl ether and 
sacrificed. Blood was collected from the inferior vena cava, 
and liver tissues were obtained.
Macroscopic examination. The abdominal cavity of rats was 
accessed by middle incision laparotomy, and the effect of MCT 
assessed macroscopically by the accumulation of peritoneal 
fluid and the color of the liver surface.
Biochemical analysis. Blood specimens were collected, and 
white blood cell (WBC) and platelet counts, as well as hemo-
globin (Hb) concentrations, were measured using an automated 
blood cell counter (Celltac α, MEK-6458, Nihon Kohden, 
Japan). Serum concentrations of aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), total bilirubin (T-Bil), 
direct bilirubin (D-Bil), indirect bilirubin (I-Bil) lactate dehy-
drogenase (LDH) and hyaluronic acid (HA) were measured by 
SRL Inc. (Tokyo, Japan).
Histologic analysis. Liver tissue was fixed in 10% neutral 
buffered formalin, embedded in paraffin, and cut serially into 
4-µm sections. Slides were stained with hematoxylin and eosin 
(H&E), and ten randomly selected high‑power fields (magnifi-
cation, x200) were examined. The degree of SOS was assessed 
by examining histological changes in sinusoidal dilatation, 
coagulative necrosis of hepatocytes, endothelial damage to 
the central vein, and sinusoidal hemorrhage (16,18,19). Each 
of these four features was graded on a 4-point scale, with 0, 
absent; 1, mild (1-30%); 2, moderate (31-60%); and 3, severe 
(61-100%). The total SOS score for each rat was calculated as 
the sum of the individual scores.
Immunohistochemistry. Tissue samples were fixed in 4% 
paraformaldehyde in phosphate buffered saline for 3 days and 
embedded in a solution of O.C.T. compound (Sakura Finetek, 
Tokyo, Japan) and 30% sucrose in 0.1 M phosphate buffer, 
pH 7.4, containing 0.05% NaN3. All tissue samples were 
sectioned at 6 µm using cryostats (Thermo Fisher Scientific, 
Waltham, MA, USA).
Immunohistochemical staining was performed with the 
Dako Envision system (Dako, Carpinteria, CA, USA), which 
uses dextran polymers conjugated with horseradish peroxi-
dase, thus avoiding contamination by endogenous biotin. 
Tissue samples were dissected out, immersed in fixative for 
4 h, dehydrated in a graded alcohol series for 24 h, embedded 
in paraffin, and cut into 4‑mm‑thick sections. Endogenous 
peroxidases were blocked by immersing the sections in 3% 
H2O2 in 100% methanol for 20 min at room temperature. 
Antigen retrieval was performed by micro-waving sections 
at 95˚C for 10 min in 0.001 M citrate buffer (pH 6.7). The 
sections were incubated with serum-free protein block 
(Dako) at room temperature for 10 min to block non‑specific 
staining, followed by incubation for 2 h at room temperature 
with primary monoclonal antibody. Peroxidase activity was 
detected with the enzyme substrate 3-amino-9-ethyl carba-
zole. As negative controls, tissue sections were incubated 
with Tris-buffered saline without the primary antibodies. All 
samples were counterstained with Meyer's hematoxylin.
Platelet aggregation was assessed by immunohistochemical 
staining of liver tissues with antibodies to platelet glycopro-
tein IIb (CD41) (1:100, orb4832; Biorbyt, Cambridge, UK) and 
P-selectin (1:50, ERP1444(2)(B); Abcam, Tokyo, Japan), the 
latter being a member of the selectin family of adhesion mole-
cules expressed on activated platelets and endothelium (20). 
Damage to sinusoidal endothelial cells was determined by 
immunostaining rat liver tissues with antibodies to rat endothe-
lial cell antigen-1 (RECA-1) (#MCZ-970R; Serotec, Oxford, 
UK) and CD34 (1:20, AF4117; R&D Systems, Inc., Minneapolis, 
MN, USA), the latter being a marker of sinusoidal capillary 
formation in liver tissue, thereby differentiating between 
normal and altered sinusoidal epithelium (21-24). Hepatocyte 
apoptosis was determined by immunostaining with antibody 
to cleaved caspase-3 (1:100, 9661; Cell Signaling Technology, 
Inc., Beverly, MA, USA). Dyeabilities of these factors were 
measured with the BZ-Analyzer software (Keyence, Osaka, 
Japan). The total stained areas were calculated from randomly 
selected images per high power field (magnification, x200) and 
compared between the two groups.
Transmission electron microscopy. Rat liver specimens were 
fixed by immersion in 2% paraformaldehyde plus 2.5% glutar-
aldehyde in phosphate buffer (pH 7.4) for 4 h at 4˚C. After 
Figure 1. Macroscopic findings in (A) the normal liver of a control rat and 
(B) the liver of a rat with MCT-induced SOS. The latter showed accumulation 
of bloody ascites. In addition, the liver surface was dark red in color.
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washing in phosphate buffer at 4˚C, the specimens were post-
fixed in 1% osmium tetraoxide for 2 h at 4˚C, washed repeatedly 
in distilled water, stained with 1% uranyl acetate for 30 min, 
dehydrated through a graded ethanol series and propylene 
oxide, and embedded in Glicidether (Selva Feinbiochemica, 
Heidelberg, Germany). Ultrathin sections were cut and mounted 
onto copper grids, stained with 1% uranyl acetate for 10 min 
and with Reynolds lead citrate for 5 min, and evaluated using 
an H7650 electron microscope (Hitachi, Tokyo, Japan) (25).
Statistical analysis. All results were expressed as the 
mean ± standard deviation (SD). Groups were compared by 
Student's t-tests. P<0.05 was considered to indicate a statisti-
cally significant difference.
Results
At sacrifice, macroscopic examination of the livers in the MCT 
group showed accumulation of bloody ascites, with the liver 
surface appearing congested and dark red in color (Fig. 1). 
These changes were not observed in the control group. The 
difference of liver size and weight was not observed between 
the two groups.
The results of complete blood counts and serum biochem-
istry tests are shown in Table I. There were no between group 
differences in WBC count and Hb concentration, although 
platelet counts were significantly lower in the MCT than 
in the control group (P=0.004). Serum concentrations of 
AST (P=0.003), ALT (P=0.008), T-Bil (P=0.012), D-Bil 
(P=0.007), I-Bil (P=0.003), LDH (P<0.001) and HA 
(P=0.0016) were all significantly higher in the MCT than in 
the control group.
Histologically, H&E staining of liver tissue showed 
higher SOS scores in the MCT than in the control group, 
with the former group showing all four histological changes: 
sinusoidal dilatation, coagulative necrosis of hepatocytes, 
endothelial damage to the central vein, and sinusoidal 
hemorrhage (Fig. 2).
CD41 protein expression was observed in the MCT group, 
especially in zone 3, but not in the control group (Fig. 3). 
Assessment of P-selectin expression showed that, in the 
control group, it was present only on the endothelial cells of 
the sinusoids (Fig. 4A). In the MCT group, however, P-selectin 
expression was observed on both sinusoidal endothelial cells 
and granularly stained platelets (Fig. 4B).
RECA-1 protein expression was markedly lower in the 
MCT (Fig. 5B) than in the control group (Fig. 5A), indicating 
that the sinusoidal lining had largely disappeared from the 
former. In contrast, CD34 expression was higher in the MCT 
group, especially in zone 3 (Fig. 6B), than in the control group 
(Fig. 6A). Similarly, cells positive for cleaved caspase-3 were 
observed in zone 3 in the MCT group 3 (Fig. 7B), but not in 
the control group. Measurements of the staining areas of MCT 
and control group are shown in Table II. In the MCT group, 
Table I. Blood counts and serum biochemistry.
 MCT group Control group
Variables (n=10) (n=10) P-value
Hb (g/dl) 14.73±1.43 14.34±1.04 0.281
WBC (x103/µl) 48.6±17.8 73.6±11.1 0.232
Plt (x103/µl) 5.87±2.7 75.78±8.3 0.004
AST (IU/l) 7,218.0±4071.3 82.9±9.1 0.003
ALT (IU/l) 1,539.2±837.7 33.4±5.4 0.008
T-Bil (mg/dl) 0.211±0.083 0.038±0.007 0.012
D-Bil (mg/dl) 0.126±0.053 0.032±0.004 0.007
I-Bil (mg/dl) 0.085±0.038 0.006±0.005 0.003
LDH (mg/dl) 5,664.9±3,700.9 312.9±158.7 <0.001
HA (ng/dl) 1,188.3±729.0 36.8±3.9 0.016
Hb, hemoglobin; WBC, white blood cell; Plt, platelet; AST, spartate 
aminotransferase; ALT, alanine aminotransferase; T-Bil, total bili-
rubin; D-Bil, direct bilirubin; I-Bil, indirect bilirubin; LDH, lactate 
dehydrogenase; HA, hyaluronic acid.
 
Figure 2. H&E staining of (A) the normal liver of a control rat and (B) the 
liver of a rat with MCT-induced SOS. The latter showed congestion and 
destruction of hepatocytes around the central vein (zone 3).
Figure 3. Immunohistochemical staining with antibody to CD41 of (A) the 
normal liver of a control rat, and (B) the liver of a rat with MCT-induced 
SOS. The latter showed staining for CD41 around the central vein, whereas 
the former showed no staining.
Figure 4. Immunohistochemical staining with antibody to P-selectin of (A) the 
normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. 
In control rats, only liver sinusoidal endothelial cells (LSECs) were positive 
for P-selectin. In MCT treated rats, LSECs and platelets were stained.
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significant excessive staining was observed in all the factors in 
comparison with the control group.
Electron microscopic examination of the MCT group 
showed many platelets containing granules in the space of 
Disse (Fig. 8).
Discussion
SOS is a veno-occlusive disease (VOD), characterized 
by hepatic injury after exposure to a drug or toxin or after 
bone marrow transplantation (26). SOS can present in acute, 
subacute and chronic forms, usually as abdominal pain 
and/or swelling, with evidence of portal hypertension and 
variable degrees of serum enzyme elevation and jaundice. 
Liver histology shows obstruction of the sinusoids in the central 
areas, along with hepatocyte necrosis and hemorrhage. Agents 
that cause SOS include cancer chemotherapeutic agents, 
particularly alkylating agents such as cyclophosphamide and 
the platinum coordination complexes cisplatin and oxaliplatin. 
The diagnosis of SOS usually depends on a typical clinical 
presentation, characterized by hepatomegaly, ascites, portal 
hypertension, weight gain and jaundice (27), or by the exclusion 
of other causes of liver injury. The usual differential diagnosis 
of SOS after bone marrow transplantation includes graft vs. 
host disease, sepsis, other forms of drug induced liver injury, 
and various forms of viral hepatitis. SOS diagnosis is usually 
supported by imaging modalities that demonstrate changes 
typical of sinusoidal obstruction. Liver biopsy is diagnostic 
but is not usually needed; moreover, concurrent coagulopathy 
or thrombocytopenia make it difficult to acquire biopsy 
samples (28). Although thrombocytopenia in SOS usually 
results from hypersplenism, decreased platelet counts have 
been observed earlier than splenomegaly (15). Therefore, this 
research focused on the role of platelets in the pathogenesis of 
SOS.
Histologic examination of the liver in patients with SOS 
shows obstruction of the sinusoids around the central vein 
(zone 3), along with hepatocyte necrosis and congestion. SOS 
may be caused by cancer chemotherapeutic and immunosup-
pressing agents. SOS was shown to be induced by oxaliplatin 
based chemotherapy in patients with CRLM, appearing as 
blue liver. Administration of MCT to rats induced SOS, with 
Figure 5. Immunohistochemical staining with antibody to RECA-1 of (A) the 
normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. 
Normal rat endothelial cells were strongly positive for RECA-1, whereas 
MCT-treated animals were weakly positive.
Figure 6. Immunohistochemical staining with antibody to CD34 of (A) the 
normal liver of a control rat and (B) the liver of a rat with MCT-induced SOS. 
CD34 expression was higher in MCT-treated rats, especially in zone 3, than 
in control rats.
Figure 7. Immunohistochemical staining with antibody to caspase-3 of (A) the 
normal liver of a control rat and (B) the liver of a rat with MCT-induced 
SOS. Normal rat liver was negative for caspase-3, whereas MCT-treated rats 
showed caspase-3 staining of hepatocytes around the central vein.
Figure 8. Electron microscopic findings of the liver of a rat with MCT‑induced 
SOS. (A) Presence of neutrophils and red blood cells in the sinusoidal space. 
(B) Many platelets containing granules (white arrows) were present in the 
space of Disse (white square in A).
Table II. Expression areas of immunohistochemical exa 
mination
 MCT group Control group
Variables (µm2) (µm2) P-value
CD41 2,405.0±2,476.3 760.0±11.8 0.014
P-selectin 14,653.7±2,324.0 11,678.1±505.0 0.034
RECA-1 51,503.0±174.0 246,664.0±64,171.0 0.001
CD34 113,914±5,336 18,720±4,780 <0.001
Cleaved 974±335 8.3±0.7 0.003
Caspase-3
RECA-1, rat endothelial cell antigen-1.
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the macroscopic appearance of blue liver and SOS detected 
histologically. Blood analysis showed that treatment with 
MCT significantly increased serum concentrations of AST, 
ALT, T‑Bil, D‑Bil and HA, with the latter reflecting injury to 
liver sinusoidal endothelial cells (LSECs) (13).
Histopathologically, administration of MCT resulted in 
sinusoidal dilatation, coagulative necrosis of hepatocytes, 
endothelial damage to the central vein, and sinusoidal 
hemorrhage. Immunohistochemical assays showed that MCT 
administration resulted in reduced RECA-1 and increased 
CD34 expression. Reduced RECA-1 expression indicated 
that the sinusoidal lining had largely disappeared. CD34 has 
been used to detect sinusoidal capillary formation in liver 
tissue and to differentiate between normal and altered sinu-
soidal epithelium (20-23).
Neutrophils and platelets participate in the patho-
genesis of severe sepsis, as well as forming neutrophil 
extracellular trapping systems (NETs) to kill pathogens 
extracellularly (29). NETs, however, have been reported 
to contribute to organ damage in patients with infectious 
diseases (30) Furthermore, sivelestat sodium, a neutrophil 
elastase inhibitor, was found to inhibit neutrophil adhe-
sion and migration to vascular endothelium during hepatic 
ischemia reperfusion and prevent liver injury (31). Platelets 
are not stained by H&E. because they lack nuclei. Platelets 
can be visualized in rats by immunostaining with antibody 
to the surface marker, CD41. Clinically, we observed EPA 
in SOS patients after liver transplantation (32,33) and after 
oxaliplatin chemotherapy (15). Platelets can be indirectly 
localized by detection of their surface markers. However, it 
was possible to directly verify the presence of platelets in the 
space of Disse around zone 3 by electron microscopy in the 
MCT group.
SOS has also been referred to as VOD in transplantation. 
Autopsy reports have shown that the pathology of human VOD 
includes reticulin deposition within sinusoids, central vein 
occlusion, hepatocyte atrophy/necrosis, sinusoidal hemorrhage, 
and sparing of portal tracts (34). Earlier histopathological 
findings of VOD can be detected by examining liver biopsy 
specimens. The affected venules show a lumen narrowed by 
a wide, edematous subendothelial zone containing a fibrous 
material and fragmented red cells. The sinusoids draining into 
these veins are congested, and the surrounding hepatocytes are 
pale and necrotic. Hemorrhage is also observed in the space 
of Disse.
Although sinusoidal fibrosis in zone 3 is regarded as an 
equivalent of early VOD, this diagnosis is not usually accepted 
unless there are significant changes in the central vein (35). 
Despite venous reflux disorder, with portal blood flowing 
back, being observed in patients with severe SOS, but venous 
obstruction or thrombosis has not been detected patho-
logically. Platelets not only form a white thrombus, but may 
cause spasms in the central vein by secreting various growth 
factors, including thromboxane A2 (TXA2), vascular endo-
thelial growth factor (VEGF)-A, transforming growth factor 
(TGF)-β and plasminogen activator inhibitor (PAI)-1 (36). 
These growth factors can explain the liver injury in SOS. For 
example, TXA2 can cause central vein occlusion and portal 
hypertension, (37) and thrombospondin-activated TGF-β can 
cause collagen deposition in the peri-sinusoidal space and 
inhibit substance exchange in the space of Disse (28). TGF-β 
can also increase serum bilirubin concentration and may be 
responsible for an abnormal ICG retention rate. PAI-1 and 
TGF-β interfere with liver regeneration by suppressing hepa-
tocyte growth factor (38). Although VEGF-A usually acts as a 
vasodilator, it can act as a vasoconstrictor under conditions of 
endothelial failure and hepatic sinusoidal injury (39). Platelet 
aggregation in the space of Disse may explain many of the 
symptoms, venous perfusion abnormalities, and portal hyper-
tension detected in SOS, findings that cannot be confirmed 
pathologically. Thus, antiplatelet agents, including vasodila-
tors such as prostaglandin E1 (40) and low dose heparin, (41) 
may prevent or reduce SOS.
In conclusion, EPA in the space of Disse has been confirmed 
in this rat model of MCT-induced liver SOS. Platelets are 
heavily involved in the development of SOS.
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